Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans

Journal of Biological Chemistry

Volumn 287, Issue 33, 2012, Pages 27796-27805

  Stravalaci, Matteo ^a   Bastone, Antonio ^a   Beeg, Marten ^a   Cagnotto, Alfredo ^a   Colombo, Laura ^a   Di Fede, Giuseppe ^b   Tagliavini, Fabrizio ^b   Cantù, Laura ^c   Del Favero, Elena ^c   Mazzanti, Michele ^c   Chiesa, Roberto ^a,d   Salmona, Mario ^a   Diomede, Luisa ^a   Gobbi, Marco ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d DULBECCO TELETHON INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; ARTIFICIAL LIPID BILAYERS; BIOLOGICAL SAMPLES; CAENORHABDITIS ELEGANS; EPIGALLOCATECHIN GALLATE; HYDROPHOBIC REGIONS; IN-VIVO; IONIC CURRENT; MISFOLDING; NEURODEGENERATIVE DISORDERS; SENSOR CHIPS; SPECIFIC RECOGNITION; SURFACE PLASMONS; TOXIC POTENTIAL;

ASSAYS; GLYCOPROTEINS; IMMUNOLOGY; MONOCLONAL ANTIBODIES; NEURODEGENERATIVE DISEASES; OLIGOMERS; PROTEINS;

SURFACE PLASMON RESONANCE;

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; EPIGALLOCATECHIN GALLATE; MONOMER; OLIGOMER;

ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; IMMUNOASSAY; ION CURRENT; LIPID BILAYER; MOLECULAR RECOGNITION; MUSCLE CONTRACTION; NONHUMAN; OLIGOMERIZATION; PHARYNGEAL MUSCLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SURFACE PLASMON RESONANCE;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; SURFACE PLASMON RESONANCE;

EID: 84865040298     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.334979     Document Type: Article

References (45)

1. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
2. Walsh, D. M., and Selkoe, D. J. (2007) A β oligomers. A decade of discovery. J. Neurochem. 101, 1172-1184
3. Holtzman, D. M., Goate, A., Kelly, J., and Sperling, R. (2011) Mapping the road forward in Alzheimer's disease. Sci. Transl. Med. 3, 114-148
4. Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C. M., Cecchi, C., and Chiti, F. (2010) A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 6, 140-147
5. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers. J. Biol. Chem. 283, 29639-29643
6. Ladiwala, A. R., Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., Vannostrand, W. E., and Tessier, P. M. (2012) Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J. Biol. Chem. DOI 10.1074/jbc.M111.329763
7. Cooper, M. A. (2002) Optical biosensors in drug discovery. Nat. Rev. Drug Discov. 1, 515-528
8. Rich, R. L., and Myszka, D. G. (2007) Higher-throughput, label-free, real-time molecular interaction analysis. Anal. Biochem. 361, 1-6
9. Sohma, Y., Hayashi, Y., Kimura, M., Chiyomori, Y., Taniguchi, A., Sasaki, M., Kimura, T., and Kiso, Y. (2005) The "O-acyl isopeptide method" for the synthesis of difficult sequence-containing peptides. Application to the synthesis of Alzheimer's disease-related amyloid β peptide (Aβ) 1-42. J. Pept. Sci. 11, 441-451
10. Taniguchi, A., Sohma, Y., Hirayama, Y., Mukai, H., Kimura, T., Hayashi, Y., Matsuzaki, K., and Kiso, Y. (2009) "Click peptide." pH-triggered in situ production and aggregation of monomer Aβ1-42. Chembiochem. 10, 710-715
11. Beeg, M., Stravalaci, M., Bastone, A., Salmona, M., and Gobbi, M. (2011) A modified protocol to prepare seed-free starting solutions of amyloid-β Aβ1-40 and Aβ1-42 from the corresponding depsipeptides. Anal. Biochem. 411, 297-299
12. Stravalaci, M., Beeg, M., Salmona, M., and Gobbi, M. (2011) Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ1-42 peptide, synthesized by depsipeptide technique. Biosens Bioelectron. 26, 2772-2775
13. Anonymous. (2011) State of aggregation (Editorial). Nat. Neurosci. 14, 399
14. Bravman, T., Bronner, V., Lavie, K., Notcovich, A., Papalia, G. A., and Myszka, D. G. (2006) Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal. Biochem. 358, 281-288
15. Link, C. D. (2005) Invertebrate models of Alzheimer's disease. Genes Brain Behav. 4, 147-156
16. Diomede, L., Cassata, G., Fiordaliso, F., Salio, M., Ami, D., Natalello, A., Doglia, S. M., De Luigi, A., and Salmona, M. (2010) Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers. Neurobiol. Dis. 40, 424-431
17. Nečas, D., and Klapetek, P. (2012) Gwyddion.Anopen-source software for SPM data analysis. Central Eur. J. Physics 10, 181-188
18. Lago, P., Rovati, L., Cantù, L., and Corti, M. A. (1993) Quasielastic light scattering detector for chromatographic analysis. Rev. Sci. Instrum. 64, 1797-1802
19. Di Fede, G., Catania, M., Morbin, M., Rossi, G., Suardi, S., Mazzoleni, G., Merlin, M., Giovagnoli, A. R., Prioni, S., Erbetta, A., Falcone, C., Gobbi, M., Colombo, L., Bastone, A., Beeg, M., Manzoni, C., Francescucci, B., Spagnoli, A., Cantù, L., Del Favero, E., Levy, E., Salmona, M., and Tagliavini, F. (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323, 1473-1477
20. Provencher, S. W. (1982) A constrained regularization method for inverting data represented by linear algebraic or integral equations. Comput. Phys. Comm. 27, 213-227
21. Paulis, D., Maras, B., Schinina, M. E., Francesco, L., Principe, S., Galeno, R., Abdel-Haq, H., Cardone, F., Florio, T., Pocchiari, M., and Mazzanti, M. (2011) The pathological prion protein forms ionic conductance in lipid bilayer. Neurochem. Int. 59, 168-174
22. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., Chiesa, R., Gobbi, M., Salmona, M., and Forloni, G. (2010) Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U.S.A. 107, 2295-2300
23. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128-1132
24. Hepler, R. W., Grimm, K. M., Nahas, D. D., Breese, R., Dodson, E. C., Acton, P., Keller, P. M., Yeager, M., Wang, H., Shughrue, P., Kinney, G., and Joyce, J. G. (2006) Solution state characterization of amyloid β-derived diffusible ligands. Biochemistry 45, 15157-15167
25. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558-566
26. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., and Wanker, E. E. (2010) EGCG remodels mature alpha-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. U.S.A. 107, 7710-7715
27. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., and Glabe, C. G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366
28. Jones, D., and Candido, E. P. (1999) Feeding is inhibited by sublethal concentrations of toxicants and by heat stress in the nematode Caenorhabditis elegans. Relationship to the cellular stress response. J. Exp. Zool 284, 147-157
29. Giaccone, G., Morbin, M., Moda, F., Botta, M., Mazzoleni, G., Uggetti, A., Catania, M., Moro, M. L., Redaelli, V., Spagnoli, A., Rossi, R. S., Salmona, M., Di Fede, G., and Tagliavini, F. (2010) Neuropathology of the recessive A673V APP mutation. Alzheimer disease with distinctive features. Acta Neuropathol. 120, 803-812
30. Ramakrishnan, M., Kandimalla, K. K., Wengenack, T. M., Howell, K. G., and Poduslo, J. F. (2009) Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid β peptide-capturing and plaque-binding monoclonal antibodies. Biochemistry 48, 10405-10415
31. Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., Barlow, E., Ebert, U., and Hillen, H. (2005) Globular amyloid β-peptide oligomer. A homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95, 834-847
32. Lambert, M. P., Velasco, P. T., Chang, L., Viola, K. L., Fernandez, S., Lacor, P. N., Khuon, D., Gong, Y., Bigio, E. H., Shaw, P., De Felice, F. G., Krafft, G. A., and Klein, W. L. (2007) Monoclonal antibodies that target pathological assemblies of Aβ. J. Neurochem. 100, 23-35
33. Lindhagen-Persson, M., Brännström, K., Vestling, M., Steinitz, M., and Olofsson, A. (2010) Amyloid-β oligomer specificity mediated by the IgM isotype. Implications for a specific protective mechanism exerted by endogenous auto-antibodies. PLoS One 5, e13928
34. Kayed, R. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489
35. Benilova, I., Karran, E., and De Strooper, B. (2012) The toxic Aβ oligomer and Alzheimer's disease. An emperor in need of clothes. Nat. Neurosci. 15, 349-357
36. Perchiacca, J. M., Ladiwala, A. R., Bhattacharya, M., and Tessier, P. M. (2012) Structure-based design of conformation- and sequence-specific antibodies against amyloid β. Proc. Natl. Acad. Sci. U.S.A. 109, 84-89
37. Štěpánek, J., Vaisocherová, H., Piliarik, M., and Homola, J. (2006) Molecular interactions in SPR sensors, in Surface Plasmon Resonance Based Sensors, pp. 69-91, Springer, Berlin, Germany
38. Hong, S., Leroueil, P. R., Majoros, I. J., Orr, B. G., Baker, J. R., Jr., and Banaszak Holl, M. M. (2007) The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 14, 107-115
39. Freir, D. B., Nicoll, A. J., Klyubin, I., Panico, S., Mc Donald, J. M., Risse, E., Asante, E. A., Farrow, M. A., Sessions, R. B., Saibil, H. R., Clarke, A. R., Rowan, M. J., Walsh, D. M., and Collinge, J. (2011) Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat. Commun. 2, 336
40. Tjernberg, L. O., Callaway, D. J., Tjernberg, A., Hahne, S., Lilliehöök, C., Terenius, L., Thyberg, J., and Nordstedt, C. (1999) A molecular model of Alzheimer amyloid β-peptide fibril formation. J. Biol. Chem. 274, 12619-12625
41. Matsumura, S., Shinoda, K., Yamada, M., Yokojima, S., Inoue, M., Ohnishi, T., Shimada, T., Kikuchi, K., Masui, D., Hashimoto, S., Sato, M., Ito, A., Akioka, M., Takagi, S., Nakamura, Y., Nemoto, K., Hasegawa, Y., Takamoto, H., Inoue, H., Nakamura, S., Nabeshima, Y., Teplow, D. B., Kinjo, M., and Hoshi, M. (2011) Two distinct amyloid β-protein (Aβ) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses. J. Biol. Chem. 286, 11555-11562
42. Kagan, B. L., Azimov, R., and Azimova, R. (2004) Amyloid peptide channels. J. Membr. Biol. 202, 1-10
43. Kawahara, M., Ohtsuka, I., Yokoyama, S., Kato-Negishi, M., and Sadakane, Y. (2011) Membrane incorporation, channel formation, and disruption of calcium homeostasis by Alzheimer's β-amyloid protein. Int. J. Alzheimers Dis. 2011, 304583
44. Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., and Lal, R. (2005) Amyloid ion channels. A common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U.S.A. 102, 10427-10432
45. Shirwany, N. A., Payette, D., Xie, J., and Guo, Q. (2007) The amyloid β ion channel hypothesis of Alzheimer's disease. Neuropsychiatr. Dis. Treat. 3, 597-612